Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Akira, Kabashima"'
Autor:
Shotaro Korehisa, Akira Kabashima, Michihiro Ichimanda, Kenji Umeda, Hidenori Koso, Kazuhiro Yada, Motoki Arakane, Hideaki Anai
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background Skeletal muscle metastasis from gastric cancer is rare and has a poor prognosis. We reported a case of gluteal muscle metastasis with peritoneal dissemination from gastric cancer during postoperative adjuvant chemotherapy. Case pr
Externí odkaz:
https://doaj.org/article/ef22f4fd9e994a09bf74498018887b70
Autor:
Eiji Oki, Akitaka Makiyama, Yuji Miyamoto, Masahito Kotaka, Hirofumi Kawanaka, Keisuke Miwa, Akira Kabashima, Tomohiro Noguchi, Kotaro Yuge, Tomomi Kashiwada, Koji Ando, Mototsugu Shimokawa, Hiroshi Saeki, Yoshito Akagi, Hideo Baba, Yoshihiko Maehara, Masaki Mori
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 454-461 (2021)
Abstract Background A previous Phase I/II study demonstrated that TAS‐102 (trifluridine/tipiracil [FTD/TPI]) plus bevacizumab (Bev) has encouraging efficacy and controllable safety for patients with previously treated metastatic colorectal cancer.
Externí odkaz:
https://doaj.org/article/13e4f89644bc4c1e85fd861d81c0eaa6
Autor:
Akira Kabashima, Hidenori Koso, Kenji Umeda, Motoki Arakane, Hideaki Anai, Kazuhiro Yada, Shotaro Korehisa, Michihiro Ichimanda
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Surgical Case Reports
Surgical Case Reports
Background Skeletal muscle metastasis from gastric cancer is rare and has a poor prognosis. We reported a case of gluteal muscle metastasis with peritoneal dissemination from gastric cancer during postoperative adjuvant chemotherapy. Case presentatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997cdac7e10f768295a1ed902bfd6d81
https://doaj.org/article/ef22f4fd9e994a09bf74498018887b70
https://doaj.org/article/ef22f4fd9e994a09bf74498018887b70
Autor:
Masahiko Kotaka, Hirofumi Kawanaka, Eiji Oki, Hiroshi Saeki, Mototsugu Shimokawa, Yuji Miyamoto, Akitaka Makiyama, Kotaro Yuge, Hideo Baba, Keisuke Miwa, Tomomi Kashiwada, Yoshihiko Maehara, Akira Kabashima, Yoshito Akagi, Masaki Mori, Tomohiro Noguchi, Koji Ando
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 454-461 (2021)
Cancer Medicine
Cancer Medicine
Background A previous Phase I/II study demonstrated that TAS‐102 (trifluridine/tipiracil [FTD/TPI]) plus bevacizumab (Bev) has encouraging efficacy and controllable safety for patients with previously treated metastatic colorectal cancer. Therefore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc0ef0418c77c9e00acf0a98b944bf5
https://doi.org/10.1002/cam4.3618
https://doi.org/10.1002/cam4.3618
Autor:
Shotaro, Korehisa, Akira, Kabashima, Sho, Nambara, Kiminori, Watanabe, Kenji, Umeda, Hidenori, Koso, Kouichiro, Tahara, Yusuke, Nakamura, Hideaki, Anai
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(6)
A 61-year-old man underwent CapeOX plus bevacizumab chemotherapyafter right hemicolectomyfor metastatic ascending colon cancer. On the 7th dayafter the first administration, he had sudden abdominal pain and nausea. Contrast-enhanced computed tomograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7993b0bf5b998309fbda014500c142ff
https://pubmed.ncbi.nlm.nih.gov/32541181
https://pubmed.ncbi.nlm.nih.gov/32541181
Autor:
Shun Sasaki, Shotaro Korehisa, Keitaro Edahiro, Daisuke Taniguchi, Yoshihiko Maehara, Kensuke Kudou, Hiroshi Saeki, Tomoko Jogo, Eiji Oki, Kosuke Hirose, Koji Ando, Yuichiro Nakashima, Ryota Nakanishi, Akira Kabashima, Nobuhide Kubo
Publikováno v:
World Journal of Surgery. 42:2894-2901
Since the clinical impact of sarcopenia on multimodal therapy for patients with esophageal cancer is not well understood, this study was conducted to determine the influence of sarcopenia on the efficacy of neoadjuvant chemoradiotherapy (NACRT) for l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcde2106072a2ddcc4fd833ee0682b25
https://doi.org/10.1007/s00268-018-4554-5
https://doi.org/10.1007/s00268-018-4554-5
Publikováno v:
Fukuoka igaku zasshi = Hukuoka acta medica. 108(1)
Although chemotherapy with oral S-1and oxaliplatin (SOX) plus bevacizumab (bev) is safe and feasible for patients with advanced or recurrent colorectal cancer, it is difficult to achieve a complete response (CR) using only chemotherapy. A 67-year-old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d96c65d153490e77b4231709ac027c1c
https://pubmed.ncbi.nlm.nih.gov/29226661
https://pubmed.ncbi.nlm.nih.gov/29226661
Autor:
Masahiko Ikebe, Shinji Uchida, Susumu Eguchi, Hideo Baba, Shoji Natsugoe, Yasunori Emi, Shoji Tokunaga, Yoshihiro Kakeji, Yutaka Ogata, Yuji Miyamoto, Yoshito Akagi, Masahiko Sakoda, Mitsuhisa Takatsuki, Hiroshi Saeki, Ken Shirabe, Hidefumi Higashi, Eiji Oki, Akira Kabashima, Toru Beppu, Yoshihiko Maehara
Publikováno v:
Annals of Surgical Oncology. 22:1067-1074
The Kyushu Study Group of Clinical Cancer (KSCC) conducted phase II trials of KSCC1002 (UMIN000001308) concerning liver resectability after first-line treatment of initially unresectable or not optimally resectable colorectal liver metastases in a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787cda69910c7cca80ce0f78cf98005c
https://doi.org/10.1245/s10434-015-4771-1
https://doi.org/10.1245/s10434-015-4771-1
Autor:
Seiji Haraoka, Kensaku Sanefuji, Soichiro Maekawa, Akira Kabashima, Koichi Kimura, Satoru Masunari
Publikováno v:
Surgical Case Reports
Background Undifferentiated high-grade pleomorphic sarcoma in gastrointestinal tract is extremely rare, and its prognosis is poor. Case presentation An 82-year-old man visited a previous hospital complaining of fever, general fatigue, and shaking chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d1319d44de33982fba0ebf8e590c49
https://doi.org/10.1186/s40792-017-0317-z
https://doi.org/10.1186/s40792-017-0317-z
Autor:
Masahito Kotaka, Hirofumi Kawanaka, Akira Kabashima, Mototsugu Shimokawa, Akitaka Makiyama, Tomomi Kashiwada, Masahiro Hamanoue, Hideo Baba, Keisuke Miwa, Masaki Mori, Eiji Oki, Yuji Miyamoto, Hiroshi Saeki, Yoshito Akagi, Takafumi Ohchi
Publikováno v:
Journal of Clinical Oncology. 37:3548-3548
3548 Background: Elderly patients are often intolerable in combination of cytotoxic agents. Recently, Trifluridine/tipiracil plus bevacizumab has been shown as good candidate for the vulnerable patients. We aimed to assess the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3a5825e1bacbbc1da5f0ec7306a9814
https://doi.org/10.1200/jco.2019.37.15_suppl.3548
https://doi.org/10.1200/jco.2019.37.15_suppl.3548